Eva Barnett
Patrimonio netto: 11 M $ in data 31/05/2026
Patrimonio netto: 11 M $ in data 31/05/2026
Eva Renee Barnett formerly worked at Immunovant, Inc., as Chief Financial & Accounting Officer from 2021 to 2025, Eli Lilly & Co., as Chief Financial Officer-Austria & Switzerland from 2011 to 2012, and AbleTo, Inc., as Chief Integration Officer in 2021.
Ms. Barnett received her undergraduate degree from DePauw University and Masters Business Admin degree from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOVANT INC 0,16% | 13/06/2025 | 327.119 ( 0,16% ) | 11 M $ | 31/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOVANT, INC. | Direttore Finanziario/CFO | 20/04/2025 |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Direttore Finanziario/CFO | 01/03/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/08/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale